Reply to Schramm, L. Comment on "Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11 , 2364".
Xiaoqing LiLan SunAndres StuckyLingli TuJin CaiXuelian ChenZhongjun WuXuhong JiangShengwen Calvin LiPublished in: Diagnostics (Basel, Switzerland) (2022)
We thank Professor Laura Schramm for her comment on the history and clarification of BDP1 nomenclature, her contribution to gene cloning [...].